No Detail Found!

Clinical efficacy and the influence of fibrinogen, homocysteine and prognosis in acute ischemic stroke patients treated with tirofiban plus TERVO stent thrombectomy

Author(s)
Peng Wang Interventional Treatment Room, Hengshui People’s Hospital, Hengshui, China
Xuejing Yin Interventional Treatment Room, Hengshui People’s Hospital, Hengshui, China
Zhanhui Yang Interventional Treatment Room, Hengshui People’s Hospital, Hengshui, China
Abstract
To evaluate the clinical efficacy and the influence of fibrinogen, homocysteine, and prognosis in acute ischemic stroke (AIS) treated with tirofiban plus TERVO stent thrombectomy. A retrospective study was conducted among 82 patients with AIS admitted to the Department of Neurology in Hengshui People's Hospital from December 2018 to December 2020 and they were evenly divided into control group and study group according to different methods. The control group received TERVO stent thrombectomy; the study group received tirofiban plus. The clinical efficacy, modified thrombolysis in cerebral infarction (mTICI) grade, serum levels of fibrinogen and homocysteine, National Institute of Health stroke scale (NIHSS), and activity of daily living (ADL) scores were compared. Significant higher clinical efficacy was observed in the study group vs. control group (all p0.05). Tirofiban plus TERVO stent thrombectomy could improve vascular recanalization rate, reduce fibrinogen and homocysteine levels and improve short-term prognosis in AIS patients.
Publication Details
Page(s) 653-658
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S2, Year: 2023

Request the full text from PASTIC

Keywords
Homocysteine, acute ischemic stroke, fibrinogen, Tirofiban, Thrombectomy, TERVO stent
0

Citations

0

Downloads

127

Views